Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Exclusion criteria

MM Michalis P. Migkos
EK Evripidis Kaltsonoudis
EP Eleftherios Pelechas
VD Vassiliki Drossou
PK Panagiota G. Karagianni
AK Athanasios Kavvadias
PV Paraskevi V. Voulgari
AD Alexandros A. Drosos
request Request a Protocol
ask Ask a question
Favorite

Patients with other ARD like SLE, scleroderma, dermatomyositis not receiving cs and/or bDMARDs and patients receiving high doses of CRs > 7.5 mg/day.

Copyright and License information: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature ©2021
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A